Oxidative markers in diabetic ketoacidosis

被引:0
作者
M.-C. Vantyghem
M. Balduyck
F. Zerimech
A. Martin
C. Douillard
S. Bans
P. M. Degand
J. Lefebvre
机构
[1] CHRU,Endocrinology Department, Biochemistry Laboratory
[2] Clinique Marc Linquette CHRU,undefined
来源
Journal of Endocrinological Investigation | 2000年 / 23卷
关键词
Oxidative markers; diabetic ketoacidosis;
D O I
暂无
中图分类号
学科分类号
摘要
Oxidative stress has been implicated in the pathogenesis of the chronic complications of diabetes mellitus but little is known in diabetic ketoacidosis (DKA). The aim of this work was to determine whether lipid peroxidation, as assessed by measuring malondialdehyde (MDA, a prooxidant) and antioxidant status (TAS, an index of antioxidant defenses), is modified in DKA, and also whether any observed abnormalities were related to metabolic disturbances. Methods: four groups of patients were studied, comprising 19 patients with DKA, massive ketonuria and plasma standard bicarbonate levels below 16 mmol/l (group 1); 20 patients with poorly controlled diabetes, glycated hemoglobin (HbA1c) above 8% and plasma bicarbonate levels above 16 mmol/l (group 2); 11 patients with well-controlled diabetes and HbA1c below 8% (group 3); and 10 non-diabetic, non-obese control subjects (group 4). Metabolic parameters, MDA levels and TAS were assessed in the plasma of the four groups of subjects. Results: mean plasma MDA and TAS values were significantly different among the four groups (respectively p<0.001 and p<0.01). Mean plasma MDA value was significantly higher in group 1 than in group 3 (p<0.02) and group 4 (p<0.001) but was not different from that in group 2. Mean plasma MDA value in group 2 was significantly lower than that in group 4 (p=0.002). Mean plasma TAS value in group 1 was significantly lower than in groups 3 (p<0.002) and 4 (p<0.05). Mean plasma TAS value was significantly lower in group 2 than in group 4 (p<0.05). Plasma MDA values in the diabetic patients (groups 1+2+3) were not related to any clinical characteristics (BMI, age, duration of the disease) or metabolic parameters (glycemia, HbA1c, bicarbonates, blood urea nitrogen, phosphatemia, lipids), while plasma TAS values correlated negatively with glycemia, osmolality and HbA1c. A significant relationship was also found between TAS and HbA1c in group 1 (p<0.05) and between MDA and HbA1c in group 3 (p<0.05). Correlations were also found between TAS and phosphatemia in group 1 (p<0.01) and between MDA and phosphatemia in group 2 (p<0.01). A positive relationship between MDA and cholesterol levels was found in group 1 (p<0.01). In conclusion, MDA values are increased and TAS values decreased in DKA and poorly controlled diabetes, and tend to correlate more with markers of diabetic imbalance than with markers of acute metabolic disturbances of DKA.
引用
收藏
页码:732 / 736
页数:4
相关论文
共 119 条
[1]  
Baynes HNW(1991)Role of oxidative stress in development of complications in diabetes Diabetes 40 405-411
[2]  
Yue DK(1989)Ascorbic acid metabolism and the polyols pathway in diabetes Diabetes 38 257-261
[3]  
Mc Lennan S(1993)Diabetes mellitus and free radicals Br. Med. Bull. 49 642-652
[4]  
Fischer E(1992)Increased lipid peroxydation in type II poorly controlled diabetic patients Diabetes Metab. 17 264-271
[5]  
Wolff SP(1995)Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus Am. J. Med. 98 469-475
[6]  
Altomare E(1997)Defective plasma antioxydant defenses and enhanced susceptibility to lipid peroxydation in uncomplicated IDDM Diabetes 46 1853-1858
[7]  
Vendemiale G(1985)Increased lipoperoxide value and gluthatione peroxydase activity in blood plasma of type 2 (non insulin dependent diabetic women) Klin. Wochenschr. 63 765-768
[8]  
Chicco D(1987)Erythrocyte lipid peroxydation and gluthathione peroxidase activities in patients with diabetes mellitus Horm Metab. Res. 19 89-90
[9]  
Procacci V(1993)Plasma malondialdehyde in type I and II diabetic patients Clin. Chem. Acta 214 227-231
[10]  
Cirelli F(1996)Erythrocyte and plasma antioxidant activity in diabetes mellitus type I Presse Med. 25 188-192